# CROSPOVIDONE

URL: https://app.greenveil.ai/ingredients/ingredient_unii_2_s7830_e561
Categories: pharma
Identifier: chebi:53248

> CROSPOVIDONE. Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 1.4 mg Compiled from 3 published data sources.

## Safety assessment

- Chemical concern: not yet assessed
- Is it a concern? We haven't assessed a concern score for this ingredient yet.
- Rationale: Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 1.4 mg

## Regulatory status

- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 1.4 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 3 %w/w
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 250 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 365 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 25.1 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 238 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SOLUTION; Potency: 36.3 mg/120ml
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 810 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 28 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 114 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: 186.8 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 2352 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 300 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 90 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 208 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 336 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 624 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 787 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 24 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 1733 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 1260 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 660 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: WAFER; Potency: 97 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: PELLET; Potency: 2 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 60 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: EMULSION; Potency: 1 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Potency: 0.5 %w/w
- US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: FILM; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Maximum daily exposure: 60 mg
- US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: SYSTEM; Maximum daily exposure: 286 mg
- US: inactive ingredient database — Route: VAGINAL; Dosage form: AEROSOL, FOAM; Potency: 1 %w/w
- US: inactive ingredient database — Route: VAGINAL; Dosage form: SUPPOSITORY; Potency: 116.1 mg
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as mixture.

## Data sources

- FDA Inactive Ingredient Database (updated 2026-01-09): https://www.fda.gov/drugs/drug-approvals-and-databases/inactive-ingredients-database-download
- FDA GSRS UNII (updated 2026-02-26): https://precision.fda.gov/uniisearch/
- openFDA Substance (updated 2026-05-24): https://api.fda.gov/other/substance.json?search=unii:2S7830E561

_Assessed by Greenveil._